Cargando…
Targeting thrombogenicity and inflammation in chronic HIV infection
Persons with HIV infection (PWH) have increased risk for cardiovascular disease (CVD), but the underlying mechanisms remain unclear. Coronary thrombosis is known to provoke myocardial infarctions, but whether PWH have elevated thrombotic propensity is unknown. We compared thrombogenicity of PWH on a...
Autores principales: | O’Brien, Meagan P., Zafar, M. Urooj, Rodriguez, Jose C., Okoroafor, Ibeawuchi, Heyison, Alex, Cavanagh, Karen, Rodriguez-Caprio, Gabriela, Weinberg, Alan, Escolar, Gines, Aberg, Judith A., Badimon, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561747/ https://www.ncbi.nlm.nih.gov/pubmed/31206016 http://dx.doi.org/10.1126/sciadv.aav5463 |
Ejemplares similares
-
Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease
por: Badimon, Juan J., et al.
Publicado: (2022) -
Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients()
por: Wu, Linghe, et al.
Publicado: (2023) -
Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019) -
Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity
por: Aharon, Anat, et al.
Publicado: (2023) -
Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Karagkiozaki, Varvara C, et al.
Publicado: (2010)